Pancreatic Cancer Research

ResearcherUniversity of CopenhagenActive in the last 2 years

Stephan J. Reshkin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9757-5908; OpenAlex author ID A5020885136. Sources: OpenAlex.

Their work

Papers
17 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
52
Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 2 papers · 2022: 3 papers · 2023: 3 papers · 2024: 2 papers · 2025: none · 2026: 2 papers

Papers 17

  1. pH-Dependent Microenvironmental Ionic Signaling in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1111/apha.70183↗
  2. Acidosis Drives Vasculogenic Mimicry in PDAC CSCs via Na+/H+ Exchanger Isoform 1 (NHE1) and Calcium Entry. Co-author DOI 10.3390/cells15100865↗
  3. Genetic Signature of Human Pancreatic Cancer and Personalized Targeting. Co-author DOI 10.3390/cells13070602↗
  4. Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its Sensitivity to Gemcitabine and C18-Gemc… Co-author DOI 10.3390/cells13090730↗
  5. Increased demand for FAD synthesis in differentiated and stem pancreatic cancer cells is accomplished by modulating FLAD1 gene expression: the inhibitory effec… Co-author DOI 10.1111/febs.16881↗
  6. Acidic Growth Conditions Promote Epithelial-to-Mesenchymal Transition to Select More Aggressive PDAC Cell Phenotypes In Vitro. Co-author DOI 10.3390/cancers15092572↗
  7. Extracellular Matrix Collagen I Differentially Regulates the Metabolic Plasticity of Pancreatic Ductal Adenocarcinoma Parenchymal Cell and Cancer Stem Cell. Co-author DOI 10.3390/cancers15153868↗
  8. Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer. Co-author DOI 10.1038/s43018-022-00470-2↗
  9. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. First author DOI 10.3390/cancers14102486↗
  10. Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition. Co-author DOI 10.3390/cancers14153737↗
  11. Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as The… Co-author DOI 10.3390/cancers13236135↗
  12. Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer. First author DOI 10.3390/ijms22083953↗
  13. KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth. Co-author DOI 10.1038/s42255-020-00315-1↗
  14. Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lipophilic Derivate of Gemcitabine. Co-author DOI 10.3390/ijms22010029↗
  15. Extracellular matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretome. Co-author DOI 10.1111/febs.14471↗
  16. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.1097/mpa.0000000000000571↗
  17. Assessment of different 3D culture systems to study tumor phenotype and chemosensitivity in pancreatic ductal adenocarcinoma. Last author DOI 10.3892/ijo.2016.3513↗

Closest collaborators

The 25 strongest of 52 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rosa Angela Cardone · 15 shared papers, 2016–2026 · strength 2.49
  2. Tiago M. A. Carvalho · 10 shared papers, 2020–2026 · strength 1.64
  3. Maria Raffaella Greco · 10 shared papers, 2016–2026 · strength 1.42
  4. Tomas Koltai · 5 shared papers, 2021–2024 · strength 1.06
  5. Stefania Cannone · 4 shared papers, 2018–2026 · strength 0.68
  6. Natalia B. Prevarskaya · 3 shared papers, 2023–2026 · strength 0.53
  7. Madelaine Magalì Audero · 3 shared papers, 2023–2026 · strength 0.53
  8. Alessandra Fiorio · 3 shared papers, 2023–2026 · strength 0.53
  9. Katrine Zeeberg · 4 shared papers, 2016–2022 · strength 0.35
  10. Albrecht Schwab · 2 shared papers, 2023–2026 · strength 0.34
  11. Stine F. Pedersen · 3 shared papers, 2016–2026 · strength 0.32
  12. Silvia Arpicco · 2 shared papers, 2020–2024 · strength 0.28
  13. Ivana Novak · 2 shared papers, 2016–2026 · strength 0.25
  14. Frauke Alves · 2 shared papers, 2016–2026 · strength 0.25
  15. Pawel Swietach · 1 shared paper, 2026 · strength 0.19
  16. Sofie Hagelund · 1 shared paper, 2026 · strength 0.19
  17. Verena Hofschröer · 1 shared paper, 2026 · strength 0.19
  18. Laura Mezzanotte · 1 shared paper, 2026 · strength 0.19
  19. Zoltán Pethő · 1 shared paper, 2026 · strength 0.19
  20. Torsten Hechler · 1 shared paper, 2026 · strength 0.19
  21. Julie Schnipper · 1 shared paper, 2026 · strength 0.19
  22. Wiktoria Błaszczak · 1 shared paper, 2026 · strength 0.19
  23. Ganga Deshar · 1 shared paper, 2026 · strength 0.19
  24. Renata Ialchina · 1 shared paper, 2026 · strength 0.19
  25. Luis A. Pardo · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.